Penetration of piperacillin/tazobactam into cancellous and cortical bone tissue

Boselli, 1999, Diffusion in bone tissue of antibiotics, Presse Med, 28, 2265 Sörgel, 1993, The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam, J Antimicrob Chemother, 31, 39, 10.1093/jac/31.suppl_A.39 Incavo, 1994, Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues, Antimicrob Agents Chemother, 38, 905, 10.1128/AAC.38.4.905 Kinzig, 1992, Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery, Antimicrob Agents Chemother, 36, 1997, 10.1128/AAC.36.9.1997 Ellner, 1981, The inhibitory quotient—A method for interpreting minimum inhibitory concentration data, JAMA, 246, 1575, 10.1001/jama.1981.03320140063033 Bouza, 1999, Micro-organisms responsible for osteo-articular infections, Bailliere's Best Pract Res Clin Rheumatol, 13, 21, 10.1053/berh.1999.0004 Cormican, 1998, In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates, Ir J Med Sci, 167, 155, 10.1007/BF02937928 Sanders, 1996, Piperacillin/tazobactam: A critical review of the evolving clinical literature, Clin Infect Dis, 22, 107, 10.1093/clinids/22.1.107 Wise, 1991, Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin, Antimicrob Agents Chemother, 35, 1081, 10.1128/AAC.35.6.1081